SUMMARY.
The Myolex (Orion) and the RapiTex (Behringwerke) latex agglutination tests for the rapid detection of elevated levels of serum myoglobin were studied prospectively in patients suspected of acute myocardial infarction, who were admitted to hospital within 8 h of pain onset. Using admission blood samples drawn 3-4± 2·0 h (mean ± SD) after onset of symptoms, the negative predictive values of both tests were too low to use these assays in the early exclusion of myocardial infarction in the emergency department. However, the negative predictive values obtained with the second blood samples, drawn 4 h later, indicated that the myoglobin agglutination test could be of value in the exclusion of myocardial infarction.
An increasing number of patients with a history of chest pain are consulting emergency departments. Besides the patient's history and electrocardiogram, serum creatine kinase (CK) and the MB isoenzyme of creatine kinase (CK-MB) are measured in some cases to ascertain or to exclude myocardial injury.
However, in spite of the absence of a cardiacspecific fraction, myoglobin appears to have a better sensitivity than CK or CK-MB during the first 10 h of the onset of acute myocardial infarction IS. This haeme protein is released into the blood by necrosis of the human cardiac muscle during the acute phase of infarction." 9 Maximum myoglobin concentrations are found 8-14 h after onset of chest pain, 10-14 h earlier than was observed for CK and CK-MBIO 12 and in most cases levels return to normal within 30 h.
Until now myoglobin has usually been measured by radioimmunoassay (RIA). However, even the fastest RIA is still time consuming and, therefore, inappropriate for rapid decisionmaking under emergency room conditions.
Recently, a rapid semi-quantitative latex agglutination test for serum myoglobin was described." IS Subsequently, the latex agglutination test RapiTex Myoglobin (Behringwerke) became commercially available and the diagnostic perfor-Correspondence: C H Konings, Departmentof Clinical Chemistry, Free University Hospital, Postbox 7057, 1007 MB Amsterdam, The Netherlands.
254 mance of this test was reported. 16 20 It was concluded that the RapiTex test could be used to identify patients without acute myocardial infarction with a high probability. However, these studies were often concerned with relatively few patients and the time interval from onset of symptoms to the collection of the blood samples was variable.
We have therefore undertaken a study in which blood samples were collected on admission, and 4 h thereafter, in patients who were admitted to hospital within 8 h of the onset of chest pain suspected as arising from acute myocardial infarction. This report summarises our experience with a new myoglobin agglutination test Myolex (Orion) compared with the Rapi'Tex test.
Patients and methods

SUBJECTS
This prospective study was performed in 110 consecutive patients admitted (within 8 h of the onset of acute chest pain) to the emergency room of the Free University Hospital, Amsterdam, from February to April 1987. Medical history and electrocardiogram were recorded and a first venous blood sample was drawn in all patients on admission. In 90 of the patients a second blood sample was collected about 4 h after hospital admission. The diagnosis of myocardial infarction was made by two cardiologists according to the World Health Organisation criteria, using CK and CK-MB as diagnostic enzymes. SPECIMEN Venous blood samples were collected in plain tubes and allowed to clot for 30 min. The sera were recovered by centrifugation (2500 g for 10 min at 20°C) and CK and CK-MB activities measured within 1 h.
The latex slide tests were later performed in batches (sera stored at -20°C), without knowing the diagnoses. watch, the procedure was as described for the Myolex test. However, the discriminator position was at 5 min according to the manufacturer's protocol.
The Myolex and Rapi'Tex assays were performed alternately by three technicians after a short familiarisation period. The analysis of a positive and negative control serum was carried out every 12th specimen or once a day.
• Time after onset of symptoms, mean ± SO.
For abbreviations see footnotes to Table I In the RapiTex method (Behringwerke Diagnostica, Marburg, West Germany), 10 JlL of the rheumatoid factor absorption medium and 50 JlL of serum or control were delivered at one of the six zones of the test plate. Using the dropper provided, about 25 JlL of the latex anti-myoglobin suspension was added. The suspensions were mixed quickly with a stick and spread over twothirds of the test zone. After starting the stop- The discriminator in the test was set at 4 min (Myolex) or 5 min (Rapi'Tex), For abbreviations see footnotes to Table I .
EVALUATION OF TEST DATA
The statistical calculations'" used In the test evaluation are given in Table I .
Results
DIAGNOSIS
Acute myocardial infarction was confirmed in 43 patients, 27 men and 16 women, mean age 66 years (range 39-91) and excluded in 67 patients, 43 men and 24 women, mean age 62 years (range 19-89).
DISCRIMINATOR SETTING
The manufacturer of the agglutination tests recommended setting the discriminator position at 3 min (Myolex) or 5 min (RapiTex). We checked the suitability of this timing in the Myolex test on all the admission samples and found the negative predictive value to be virtually the same whether the discriminator was at 3,4 or 5 min (Table 2 ). Using the second blood samples collected about 4 h after admission it was noted that, with the discriminator at 3 min, the negative predictive value of the Myolex test was considerable lower due to the high false negative fraction (0'28) in the test ( Table 2 ). Because the false positive fraction in the Myolex test with the discriminator at 5 min was twice that at 4 min, we recommend the latter time.
AGGLUTINATION TEST AND BLOOD SAMPLE AT ADMISSION Table 3 compares the performance and the diagnostic values of the Myolex and RapiTex
The discriminator in the test was set at 4 min (Myolex) or 5 min (Rapi'Tex), For abbreviations see footnotes to Table I. agglutination test, using the first blood sample from 110 patients. The time from the onset of symptoms to blood sampling was 3·4 ±2·0 h (mean ±SD). It was surprising to find that the tests were positive in only 33% (Myolex) and 47% (RapiTex) of the patients with acute myocardial infarction.
AGGLUTINATION TEST AND SECOND BLOOD SAMPLE Table 4 summarises the performance of the tests carried out on the second blood sample from 90 patients 7·5 ±2·0 h after the onset of pain. In these samples 93% and 95% of the Myolex and the RapiTex tests respectively were positive in the patients with myocardial infarction.
Discussion
PRACTICABILITY OF THE AGGLUTINATION
TESTS
The incorporation of dry reagents on the test card of the Myolex test proved very convenient. Moreover, the position of the blank relative to the test made it easier to judge the developing agglutination pattern at the test position. Thus the absence of a 'negative' myoglobin control serum in the Myolex kit was not a major disadvantage. In fact the separate analysis of the 'negative' control serum of RapiTex was a disadvantage in that it entailed more expense. Also in contrast to the Myolex procedure, the absorption solution and the anti-myoglobin latex suspension in the RapiTex test had to be added by micropipette and the enclosed dropper respectively. A further observation on the RapiTex technique is that it was possible to delay agglutination if the reaction card was tilted too fast. This was less critical in the Myolex procedure. The validity of the agglutination test must be carefully evaluated in the emergency laboratory. In this context we refer to the report of Hangaard et al., 15 who found an increase in the false negative test results with an in-house latex test in such an 'around the clock' situation.
REPORTED STATISTICAL VALUES OF THE
RAPITEX TEST
Previous reports'V" noted that the major importance of the myoglobin agglutination test was its high negative predictive value when performed in the first hours after the onset of symptoms. In these studies too, blood sampling was carried out on admission, shortly after the onset of chest pain.
The diagnostic predictivity of a test is a function of the prevalence of disease. Therefore, to compare the reported negative predictive values of the RapiTex test (Table 5) , we have recalculated-' these figures to the prevalence (0'39) of acute myocardial infarction in our patient group. TEST 
RESULTS OF THE FIRST SAMPLE
It is obvious that our data on the Myolex and RapiTex tests do not confirm earlier results. We presume that the mean time elapsed between onset of pain and collection of the first blood sample on admission was quite different in these studies and therefore accounted for the discrepancy. In our group of patients this time period was recorded and was quite short (2,9 ± 1·8 h, range 0'7-8,0) for patients with myocardial infarction. This explains the high number of false negative Myolex and RapiTex results. TEST 
RESULTS OF THE SECOND SAMPLE
The diagnostic power of the myoglobin agglutination test was improved by the analysis of the second blood sample, which was collected on average 7·5 h after the onset of symptoms. The sensitivity and the negative predictive value of the Myolex and the RapiTex test results were higher than obtained with the first blood sample (Table  4) . Surprisingly, no agglutination was observed in the serum of one patient 8 h after the onset of chest pain in both tests. Two patients showed a negative Myolex test 6 hand 4 h and one patient a negative RapiTex test 6·5 h after onset of symptoms. In all of these patients with negative test results, CK and CK-MB were in the reference range. The lower specificity of the RapiTex test was due to the high false positive fraction.
INTERPRETATION OF SEQUENTIAL TESTING
The Myolex and the RapiTex tests were carried out on the blood sample at admission and, if a negative test result was obtained, again 4 h later. This sequential approach was of no greater diagnostic value than assaying the later sample alone.
